Transcript: People who live with diabetes must carefully monitor and manage their blood glucose levels. But that can be difficult during extreme weather. Graffeo: “There are so ...

Continuous glucose monitoring with low-glucose alerts shows potential for reducing hypoglycemia risk in insulin-treated ...

Chronic diseases require a lifetime of long-term follow-up. Randomised controlled trials are considered the most robust ...

Relatively inexpensive and accessible self-management interventions to help people manage Type 2 diabetes have been found to significantly reduce the blood sugar marker used to diagnose and manage the ...

Evaluating current formulary access for the 25 drugs selected for Drug Price Negotiation in Medicare Part D shows several selected drugs have ...

The agency cited quality issues at facilities testing Dexcom’s G6 and G7 monitors, including inadequate validation and risk ...

As people age, it's normal for them to suffer from some minor memory problems. Dementia, however, is not a normal part of ...

However, limited evidence exists regarding its prognostic role in patients with diabetes mellitus (DM) undergoing percutaneous coronary intervention (PCI), which we sought to explore in this analysis.

To comply with MHPAEA, the new rule requires insurers to collect and analyze outcome data, such as rates of out-of-network utilization and denied claims, to assess whether the treatment limits imposed ...

In 37% of cases, patients said the doctor had little time to discuss patient-identified information. US cancer patients have reported positive and negative experiences when sharing patient ...

The Food and Drug Administration (FDA) has expanded the approval of Baqsimi (glucagon) nasal powder to include the treatment of severe hypoglycemia in patients aged 1 year and older with diabetes.

TALLAHASSEE — Business groups are raising privacy concerns after state regulators requested detailed data on Floridians' prescription drugs, including patients' names and dates of birth and ...